CoChat

Dysregulated bioenergetics: a key regulator of joint inflammation

Open access

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Objectives This study examines the relationship between synovial hypoxia and cellular bioenergetics with synovial inflammation. Methods Primary rheumatoid arthritis synovial fibroblasts (RASF) were cultured with hypoxia, dimethyloxalylglycine (DMOG) or metabolic intermediates. Mitochondrial respiration, mitochondrial DNA mutations, cell invasion, cytokines, glucose and lactate were quantified using specific functional assays. RASF metabolism was assessed by the XF24-Flux Analyzer. Mitochondrial structural morphology was assessed by transmission electron microscopy (TEM). In vivo synovial tissue oxygen (tpO2 mmHg) was measured in patients with inflammatory arthritis (n=42) at arthroscopy, and markers of glycolysis/oxidative phosphorylation (glyceraldehyde 3-phosphate dehydrogenase (GAPDH), PKM2, GLUT1, ATP) were quantified by immunohistology. A subgroup of patients underwent contiguous MRI and positron emission tomography (PET)/CT imaging. RASF and human dermal microvascular endothelial cells (HMVEC) migration/angiogenesis, transcriptional activation (HIF1α, pSTAT3, Notch1-IC) and cytokines were examined in the presence of glycolytic inhibitor 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO). Results DMOG significantly increased mtDNA mutations, mitochondrial membrane potential, mitochondrial mass, reactive oxygen species and glycolytic RASF activity with concomitant attenuation of mitochondrial respiration and ATP activity (all p<0.01). This was coupled with altered mitochondrial morphology. Hypoxia-induced lactate levels (p<0.01), which in turn induced basic fibroblast growth factor (bFGF) secretion and RASF invasiveness (all p<0.05). In vivo glycolytic markers were inversely associated with synovial tpO2 levels <20 mm Hg, in contrast ATP was significantly reduced (all p<0.05). Decrease in GAPDH and GLUT1 was paralleled by an increase in in vivo tpO2 in tumour necrosis factor alpha inhibitor (TNFi) responders. Novel PET/MRI hybrid imaging demonstrated close association between metabolic activity and inflammation. 3PO significantly inhibited RASF invasion/migration, angiogenic tube formation, secretion of proinflammatory mediators (all p<0.05), and activation of HIF1α, pSTAT3 and Notch-1IC under normoxic and hypoxic conditions. Conclusions Hypoxia alters cellular bioenergetics by inducing mitochondrial dysfunction and promoting a switch to glycolysis, supporting abnormal angiogenesis, cellular invasion and pannus formation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2015-208476

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Dimethyloxalylglycine (DMOG) induces mitochondrial dysfunction and glycolytic metabolism in RASF. (A–J) Box plots representing frequency of mitochondrial DNA mutation (A), reactive oxygen species (ROS) (B), mitochondrial membrane potential (MMP) (C), mitochondrial mass (MM) (D), ATP (E) extracellular acidification rates (ECAR) (F), basal oxygen consumption rates (OCR) (G), ATP synthesis (H), maximal respiration (I) and spare respiratory capacity (J), quantification in response to DMOG (1 mM) or vehicle control (1 mM) in primary RASF (n=7). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant.
Figure 1 Dimethyloxalylglycine (DMOG) induces mitochondrial dysfunction and glycolytic metabolism in RASF. (A–J) Box plots representing frequency of mitochondrial DNA mutation (A), reactive oxygen species (ROS) (B), mitochondrial membrane potential (MMP) (C), mitochondrial mass (MM) (D), ATP (E) extracellular acidification rates (ECAR) (F), basal oxygen consumption rates (OCR) (G), ATP synthesis (H), maximal respiration (I) and spare respiratory capacity (J), quantification in response to DMOG (1 mM) or vehicle control (1 mM) in primary RASF (n=7). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant.CC BY-NC · PubMed Central
Figure 2 Hypoxia induces lactate, abnormal mitochondrial morphology, invasiveness and secretion of bFGF in RASF in vitro. RASF were cultured under normoxic and 3% hypoxic conditions for 24 h. Box plots represent glucose (A) and lactate (B) levels in RASF cultured supernatants (n=7). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant. (C,D) Representative transmission electron microscopy images of RASF mitochondria under normoxic and 3% hypoxic conditions. Regular shaped mitochondria indicated by black arrows and irregular elongated mitochondria indicated by red arrows. Invasion was assessed using Biocoat Transwell invasion chambers following lactic acid treatment (1 mM) and representative images were taken (E,F). Following 24 h stimulation, invading cells attached to lower membrane were fixed (1% glutaraldehyde) and stained (0.1% crystal violet) (×40). (G) Quantification of RASF invasion (n=7). Quantification of bFGF (H), VEGF (I) and PIGF (J) in RASF supernatants following culture with lactic acid (1 mM) compared with basal (n=8). *p<0.05 statistically significant.
Figure 2 Hypoxia induces lactate, abnormal mitochondrial morphology, invasiveness and secretion of bFGF in RASF in vitro. RASF were cultured under normoxic and 3% hypoxic conditions for 24 h. Box plots represent glucose (A) and lactate (B) levels in RASF cultured supernatants (n=7). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant. (C,D) Representative transmission electron microscopy images of RASF mitochondria under normoxic and 3% hypoxic conditions. Regular shaped mitochondria indicated by black arrows and irregular elongated mitochondria indicated by red arrows. Invasion was assessed using Biocoat Transwell invasion chambers following lactic acid treatment (1 mM) and representative images were taken (E,F). Following 24 h stimulation, invading cells attached to lower membrane were fixed (1% glutaraldehyde) and stained (0.1% crystal violet) (×40). (G) Quantification of RASF invasion (n=7). Quantification of bFGF (H), VEGF (I) and PIGF (J) in RASF supernatants following culture with lactic acid (1 mM) compared with basal (n=8). *p<0.05 statistically significant.CC BY-NC · PubMed Central
Figure 3 GAPDH, ATP5B, GLUT1 and PKM2 expression in synovial tissue is associated with in vivo synovial pO2 levels. Representative images and semiquantification of immunohistochemical staining for glycolytic and oxidative phosphorylation markers GAPDH, ATP5B, GLUT1 and PKM2 in lining layer (LL) and sublining layer (SL) of synovial tissue. GAPDH, ATP5B, GLUT1 and PKM2 quantification was categorised into patients with in vivo pO2 levels >20 mm Hg versus <20 mm Hg. Quantification was performed using a semiquantitative scoring method (0–4). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant.
Figure 3 GAPDH, ATP5B, GLUT1 and PKM2 expression in synovial tissue is associated with in vivo synovial pO2 levels. Representative images and semiquantification of immunohistochemical staining for glycolytic and oxidative phosphorylation markers GAPDH, ATP5B, GLUT1 and PKM2 in lining layer (LL) and sublining layer (SL) of synovial tissue. GAPDH, ATP5B, GLUT1 and PKM2 quantification was categorised into patients with in vivo pO2 levels >20 mm Hg versus <20 mm Hg. Quantification was performed using a semiquantitative scoring method (0–4). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant.CC BY-NC · PubMed Central
Figure 4 Co-localisation of metabolic activity and inflammation in vivo using hybrid PET/MRI images. Contiguous CT, PET and MRI scans from patients with rheumatoid arthritis were obtained and then fused to create hybrid PET/MRIs to co-localise metabolic activity and inflammation in the joint. (A) Representative images of axial CT slice (1), axial PET/CT (2), axial contrast-enhanced MRI (3) and hybrid PET/MRI fusion (4). (B) Representative images of four patients demonstrating co-localisation of metabolic activity and inflammation and in vivo synovial pO2 levels.
Figure 4 Co-localisation of metabolic activity and inflammation in vivo using hybrid PET/MRI images. Contiguous CT, PET and MRI scans from patients with rheumatoid arthritis were obtained and then fused to create hybrid PET/MRIs to co-localise metabolic activity and inflammation in the joint. (A) Representative images of axial CT slice (1), axial PET/CT (2), axial contrast-enhanced MRI (3) and hybrid PET/MRI fusion (4). (B) Representative images of four patients demonstrating co-localisation of metabolic activity and inflammation and in vivo synovial pO2 levels.CC BY-NC · PubMed Central
Figure 5 3PO inhibits proinflammatory mechanisms in RASF and HMVEC cells. RASF (left panel) and HMVEC (right panel) were cultured in the presence of the glycolytic inhibitor 3PO (20 µM). Invasion was assessed using Biocoat Transwell invasion chambers following RASF treatment with 3PO (n=3) and representative images and quantification is shown in (A). Representative images of inhibition of RASF migration following 3PO treatment and quantification of wound repair (n=6) are shown in (B). (C) Quantification of interleukin (IL) 6, IL-8, MCP-1 and RANTES in RASF supernatants following RASF culture with 3PO compared with basal (n=9). Representative images and quantification of HMVEC tube formation in response to 3PO (D). Quantification of IL-6, IL-8, GRO and RANTES in HMVEC supernatants following culture with 3PO compared with basal (n=8) (E). Representative western blots are shown in (F) for HIF1α, pSTAT3, tSTAT3, Notch1 and βactin in both K4IM (left panel) and HMVEC (right panel) following 3PO treatment under hypoxia. *p<0.05 statistically significant.
Figure 5 3PO inhibits proinflammatory mechanisms in RASF and HMVEC cells. RASF (left panel) and HMVEC (right panel) were cultured in the presence of the glycolytic inhibitor 3PO (20 µM). Invasion was assessed using Biocoat Transwell invasion chambers following RASF treatment with 3PO (n=3) and representative images and quantification is shown in (A). Representative images of inhibition of RASF migration following 3PO treatment and quantification of wound repair (n=6) are shown in (B). (C) Quantification of interleukin (IL) 6, IL-8, MCP-1 and RANTES in RASF supernatants following RASF culture with 3PO compared with basal (n=9). Representative images and quantification of HMVEC tube formation in response to 3PO (D). Quantification of IL-6, IL-8, GRO and RANTES in HMVEC supernatants following culture with 3PO compared with basal (n=8) (E). Representative western blots are shown in (F) for HIF1α, pSTAT3, tSTAT3, Notch1 and βactin in both K4IM (left panel) and HMVEC (right panel) following 3PO treatment under hypoxia. *p<0.05 statistically significant.CC BY-NC · PubMed Central
Figure 6 Successful TNFi treatment increases synovial pO2 levels while decreasing expression of GAPDH and GLUT1. Improvements in synovial pO2 levels in patients who responded to TNFi treatment after 3 months compared with non-responders (A). (B–F) Representative images and semiquantification of immunohistochemical staining for glycolytic marker GAPDH in the lining layer (LL) and sublining layer (SL) of synovial tissue and GLUT1 in the SL of synovial tissue. GAPDH and GLUT1 quantification was categorised into patients who were either responders or non-responders to treatment. Quantification was performed using a semiquantitative scoring method (0–4). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant.
Figure 6 Successful TNFi treatment increases synovial pO2 levels while decreasing expression of GAPDH and GLUT1. Improvements in synovial pO2 levels in patients who responded to TNFi treatment after 3 months compared with non-responders (A). (B–F) Representative images and semiquantification of immunohistochemical staining for glycolytic marker GAPDH in the lining layer (LL) and sublining layer (SL) of synovial tissue and GLUT1 in the SL of synovial tissue. GAPDH and GLUT1 quantification was categorised into patients who were either responders or non-responders to treatment. Quantification was performed using a semiquantitative scoring method (0–4). Boxes represent the 25th to 75th centiles, lines within the boxes represent the median, and lines outside the boxes represent the 10th and 90th centiles. *p<0.05 statistically significant.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 242

Metadata

Authors
Biniecka, M., Canavan, M., McGarry, T., Gao, W., McCormick, J., Cregan, S., Gallagher, L., Smith, T., Phelan, J. J., Ryan, J., O'Sullivan, J., Ng, C. T., Veale, D. J., & Fearon, U.
Affiliations
  • St. Vincent's University Hospital (IE)
  • Trinity College Dublin (IE)
  • University College Dublin (IE)
  • Singapore General Hospital (SG)
Corresponding author
Fearon, U
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2016-12
Volume
75
Issue
12
Pages
2192-2200
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2311703587
Cited by
236
References
62
Citations by year
2026: 22 · 2025: 27 · 2024: 21 · 2023: 20 · 2022: 28 · 2021: 31 · 2020: 26 · 2019: 17 · 2018: 19 · 2017: 22 · 2016: 3
FWCI
21.64
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of the Rheumatic Diseases (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
Health Research Board
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
rheumatoid arthritis, synovial fibroblasts, cellular bioenergetics, mitochondrial respiration, mitochondrial DNA mutations, glycolysis, lactate, angiogenesis, HIF-1α, STAT3, Notch1, TNF-alpha inhibitors, PET/MRI imaging, synovitis, oxidative phosphorylation, dimethyloxalylglycine, basic fibroblast growth factor, TNF-α
MeSH terms
Amino Acids, Dicarboxylic, Hypoxia, Arthritis, Rheumatoid, Cell Movement, Cells, Cultured, DNA, Mitochondrial, Energy Metabolism, Fibroblasts, Glucose, Humans, Joints, Mitochondria, Synovial Membrane, Cytokines, Reactive Oxygen Species, Lactic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysregulated bioenergetics: a key regulator of joint inflammation. https://app.cochat.ai/papers/10.1136/annrheumdis-2015-208476
The paper
Biniecka, M., Canavan, M., McGarry, T., Gao, W., McCormick, J., Cregan, S., Gallagher, L., Smith, T., Phelan, J. J., Ryan, J., O'Sullivan, J., Ng, C. T., Veale, D. J., & Fearon, U. (2016). Dysregulated bioenergetics: a key regulator of joint inflammation. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2015-208476

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.